Alqudah Muhammad, Stubbs Michelle Anne, Al-Masaeed Mahmoud, Fernandez Ritin
University of Newcastle, Australia.
University of Newcastle, Australia.
J Pediatr Nurs. 2025 Jan-Feb;80:e272-e281. doi: 10.1016/j.pedn.2024.12.018. Epub 2025 Jan 7.
This review aims to investigate parents' preference for and use of Ibuprofen and Paracetamol in managing and treating children's fevers as well as the factors influencing their decision-making and practices.
Parents globally face concern over managing children's fever, seeking relief while ensuring safety, often relying on accessible medications like Paracetamol and Ibuprofen.
The review included quantitative studies involving parents and caregivers managing fever in children aged 0-17 years. Studies published in English or in other languages with an English language version from January 2000 to March 2024 were included, excluding hospital-based or healthcare professional-managed studies.
Searches were conducted using MEDLINE, PubMed, SCOPUS, and CINAHL databases using specific search strategies. Titles and abstracts were screened online, and full reports were obtained for any publication considered useful for this overview. Methodological quality was assessed independently by two reviewers using the JBI critical appraisal instrument. Data extraction was performed in Excel, and statistical meta-analysis was undertaken using JBI SUMARI software.
Approximately 27.4 % of participants utilized Ibuprofen, while 64.3 % opted for Paracetamol. Subgroup analyses revealed that 29.8 % and 63.2 % administered Ibuprofen and Paracetamol to children under five. Additionally, 20.3 % alternated between these medications. Syrup emerged as the preferred mode of administration, with prominent parental involvement in dosage determination. Factors influencing medication choices included efficacy, safety profile, age, weight, ease of administration, and healthcare provider recommendations.
The prevalence of Ibuprofen and Paracetamol usage for pediatric fever management varies significantly. Parental involvement is prominent, guided by factors like efficacy and healthcare provider recommendations. Understanding these dynamics is crucial for informed decision-making and optimizing pediatric medication practices.
This review highlights the importance of enhancing parental education on antipyretic use, emphasizing safe dosage practices and clear communication with healthcare providers. Healthcare professionals should address misconceptions and provide tailored guidance, fostering more effective and safer fever management strategies for children.
本综述旨在调查家长在处理和治疗儿童发热时对布洛芬和对乙酰氨基酚的偏好及使用情况，以及影响他们决策和行为的因素。
全球家长都面临着处理儿童发热的问题，他们在确保安全的同时寻求缓解方法，常常依赖对乙酰氨基酚和布洛芬等容易获取的药物。
本综述纳入了涉及家长和照顾者处理0至17岁儿童发热的定量研究。纳入了2000年1月至2024年3月以英文或有英文版本的其他语言发表的研究，排除基于医院或由医疗保健专业人员管理的研究。
使用特定搜索策略在MEDLINE、PubMed、SCOPUS和CINAHL数据库中进行检索。在线筛选标题和摘要，获取任何被认为对本综述有用的出版物的完整报告。由两名评审员使用JBI批判性评价工具独立评估方法学质量。在Excel中进行数据提取，并使用JBI SUMARI软件进行统计荟萃分析。
约27.4%的参与者使用布洛芬，而64.3%选择对乙酰氨基酚。亚组分析显示，29.8%和63.2%的家长分别给五岁以下儿童服用布洛芬和对乙酰氨基酚。此外，20.3%的家长在这两种药物之间交替使用。糖浆剂是首选的给药方式，家长在剂量确定方面参与度很高。影响药物选择的因素包括疗效、安全性、年龄、体重、给药便利性以及医疗保健提供者的建议。
布洛芬和对乙酰氨基酚用于儿童发热管理的流行率差异显著。家长的参与很突出，受疗效和医疗保健提供者建议等因素的指导。了解这些动态对于做出明智决策和优化儿科用药实践至关重要。
本综述强调了加强家长对退烧药使用教育的重要性，强调安全用药剂量做法以及与医疗保健提供者的清晰沟通。医疗保健专业人员应消除误解并提供量身定制的指导，为儿童培养更有效、更安全的发热管理策略。
